AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals’ First Quarter 2020 Financial Results Conference Call. As a reminder, this conference call is being recorded. I would now ...
“2020 was a remarkable year of accomplishment and building momentum for TFF Pharmaceuticals, due to success in achieving key milestones in our two-pronged business model of internal development of ...
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company, and Augmenta Bioworks, Inc., a biotechnology company enabling breakthroughs in medicine through immune profiling, ...
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) ...
Austin-based TFF Pharmaceuticals said Tuesday that it has raised $25.9 million to expand its product offerings through a private stock placement The company, which spun off from Austin-based Lung ...
AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback